Advanced Filters
noise

Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 2,198 clinical trials
D Desirae Dufner, Dr

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

The primary purposes of this study are to determine the safety and tolerability of PQ203 in patients with advanced solid tumors including triple negative breast cancer (TNBC), and to determine a recommended Phase 2 dose level for future studies in TNBC.

18 years of age All Phase 1
J Jennifer S Temel, MD

Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer

Many people living with metastatic breast cancer face challenging symptoms and frequent medical visits. At the same time, conversations about personal goals, values, and preferences for care may not always happen as early or as often as patients and families would like. This multi-site study will test the effectiveness of …

18 years of age All Phase N/A
M Márta Hock, Phd

Body Image and Physical Activity of Women with Breast Cancer

The goal of this self-initiated questionnaire-based follow-up clinical trial is to map the body image and physical activity of Hungarian women treated for breast cancer. The main questions it aims to answer are: How body image changes during different treatments among women treated for breast cancer? How is physical activity …

18 - 80 years of age Female Phase N/A
J Jiuda Zhao

Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer

This study aims to elucidate the therapeutic efficacy of electroacupuncture in managing chemotherapy-induced gastrointestinal symptom clusters through clinical research. Building upon this foundation, multi-omics analyses will be conducted to investigate the regulatory effects and underlying mechanisms of electroacupuncture on gastrointestinal symptoms. Ultimately, genomic studies will be performed to further clarify …

18 - 75 years of age All Phase 3
A Aline Van der Vorst, MD

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

This study is a prospective, non-randomized clinical study aimed at investigating the potential benefits of continuous positive airway pressure (CPAP) support during radiotherapy for breast cancer. CPAP is a device commonly used to support breathing, for example in patients with sleep apnea. The investigators expect a reduction in radiation doses …

40 - 80 years of age Female Phase 2/3
T Tiffany Tran

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.

40 - 89 years of age Female Phase N/A
L Lubina Arjyal, MD

A Study of the TheraBionic P1 Device in Breast Cancer

The goal of this clinical trial is to learn if adding cancer-specific amplitude-modulated radiofrequency electromagnetic field therapy (TheraBionic P1 device) to the treatment of resectable early-stage breast cancer will affect the pathological response.

22 years of age Female Phase N/A
T Ting Zhang, Prof.

Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer

The goal of this clinical trial is to compare the efficacy and safety in patients with lymph node-positive HR+/HER2- breast cancer. The main questions it aims to answer are: Can the incorporation of intensified radiation to the tumor (tumor boost) enhance the pCR rate on the basis of neoadjuvant immuno-chemotherapy? …

18 - 85 years of age Female Phase 2
L Liaoning Cancer Hospital & Institute

Optimal Application Timing of ADC Drugs for Advanced Breast Cancer

This study plans to initiate a prospective, randomized controlled trial to investigate the optimal timing of antibody drug conjugate (ADC) therapy in the management of advanced Human Epidermal Growth Factor Receptor 2 (HER2)-negative breast cancer. Primary Objective: To compare the difference in PFS2 (Time from randomization to disease progression after …

18 - 75 years of age Female Phase 2
M Mridula George, MD

Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer

This is an open-label phase 2 study to evaluate the pCR rate in patients diagnosed with HER2 positive breast cancer treated on an adaptive clinical trial design. Tumors will undergo testing using a novel molecular phosphoprotein-based biomarker assay, HER2 Activation Response Predictive Signature (HARPS) to identify HARPS-positive breast cancers. To …

18 - 90 years of age All Phase 2

Simplify language using AI